The Renal Association and the British Renal Society believe that Black Lives Matter

Kidney disease is more common in people from BAME (Black, Asian and Minority Ethnic) communities. People from BAME communities are more likely to need a kidney transplant, but less likely to receive one. 1,2

NHS staff are drawn from across BAME communities but are less likely to proceed to senior roles than their white counterparts.3 More recently our BAME colleagues have suffered increased mortality from COVID-19.4

The Renal Association and British Renal Society have worked hard supporting progress in this area.  We remain ever more committed to ensuring BAME patients have access to the best treatments to prevent and treat kidney disease, and supporting our BAME colleagues to progress fairly and safely in the workplace. We will strive to ensure that there are no differences in outcome due to overt or structural racism.